Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
  • Franklin Micro Cap Value Fund to change name
    https://www.sec.gov/Archives/edgar/data/856119/000174177324001091/c497.htm
    497 1 c497.htm 189 P1 03/24
    189 P1 03/24
    IMPORTANT NOTICE REGARDING CHANGE IN INVESTMENT POLICY
    SUPPLEMENT DATED MARCH 4, 2024
    TO THE PROSPECTUS DATED MARCH 1, 2024
    OF
    Franklin MicroCap Value Fund
    (a series of Franklin Value Investors Trust)
    The prospectus of the Fund is amended as follows:
    I. The following is added as the first paragraph under the “Fund Summary” and “Fund Details” headings in the prospectus:
    As approved by the Board of Trustees of the Trust, effective on or about May 22, 2024, the Fund will be renamed the Franklin Mutual Small-Mid Cap Value Fund and the Fund’s 80% investment policy will be changed so that the Fund will invest, under normal circumstances, at least 80% of its net assets in investments of small-capitalization and mid-capitalization companies. For purposes of this policy, small- and mid-capitalization companies would be defined as companies with market capitalizations not exceeding either: (1) the highest market capitalization in the Russell 2500 Index; or (2) the 12-month average of the highest market capitalization in the Russell 2500 Index, whichever is greater, at the time of purchase. In addition, effective on or about May 22, 2024: (i) the Fund’s tailored benchmark index will change to the Russell 2500 Value Index; (ii) the Fund’s investment management fee schedule will be reduced from an annual rate of 0.75% of the average daily net assets of the Fund to an annual rate of: 0.70% of the average daily net assets of the Fund up to and including $500 million; and 0.65% of the average daily net assets of the Fund in excess of $500 million; (iii) the Fund’s investment manager will waive fees and/or reimburse operating expenses (excluding Rule 12b-1 fees, acquired fund fees and expenses, and certain non-routine expenses or costs) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.90% for each share class until February 28, 2026; and (iv) Steve Raineri, a senior portfolio manager of the Fund’s investment manager, will be added as the lead portfolio manager of the Fund.
    The Fund reserves the right to change the above at any time.
    Please keep this supplement with your prospectus for future reference.
  • frozen markets, range-bound
    In all our accounts, ie retirement and non retirement about 31% stocks, mostly US
    YTD up 1.5% with almost all gains of course in Large Caps. Rotation to my Energy, International etc has stalled out
  • frozen markets, range-bound
    That fund’s #2 holding is DECK (3.5% or so), the other stock joining the S&P 500. Per a check on the fund’s website
  • Goldman's latest call -- this time is different

    Goldman Sachs says this tech stock rally is grounded in reality
    https://www.marketwatch.com/story/goldman-sachs-says-this-tech-stock-rally-is-grounded-in-reality-9ee03ea6
    David Kostin, in a note to clients, says companies that have an enterprise value-to-sales ratio of at least 10 account for 24% of the total U.S. stock market cap, versus 28% in 2021 and 35% in the late 90s tech bubble.
    ...
    Kostin notes the number of stocks with those elevated valuation ratios has declined very sharply. “Unlike the broad-based ‘growth at any cost’ in 2021, investors are mostly paying high valuations for the largest growth stocks in the index. This dynamic more closely resembles the Tech Bubble than 2021. However, in contrast with the late ’90s, we believe the valuation of the Magnificent 7 is currently supported by their fundamentals

    (he also says the cost of capital is lower now, which is good for stocks)
    ... that said, my reading is that they're essentially saying "this time is different" -- which often are the 4 most dangerous words in investing & finance. And this being a prognostication by Goldman, my continuing reaction is to 'fade' such advice if I want to preserve capital and/or make money for ME.
    My own sense? There's a bullish euphoria starting to build in the markets/financialp0rn punditry -- FOMO is keeping stocks elevated these days and my sense* is that this run doesn't go on too much longer before consolidation. IMO, the only thing that will goose stocks significantly higher is if/when rates come down and the purported trillions in cash and cash-like assets move back into equities. But Valuation? WCoC? Not going to do it by itself.
    * somewhat more accurate than a 'Magic Eight Ball'
  • frozen markets, range-bound
    @WABAC: we both hold XMHQ. I was surprised to find SMCI as its top holding. Surprised because the same stock is the top holding of two of my go-go growth funds. Haircuts ensued last Friday.
    I read that SMCI is moving to the 500. I guess we'll stumble along somehow.
  • Barron's Best Fund Families
    Barron’s BEST FUND FAMILIES. They were evaluated in 5 categories to produce overall weighted scores – US equity, world equity, mixed assets, taxable bonds, muni bonds. Only active funds were considered, but that meant factor- and active- ETFs. Excluded were Janus Henderson, Dodge & Cox, etc, as they didn’t have enough funds within the 5 categories. Some funds from last year were merged into others, so skipped (but Putnam/Franklin Templeton was too recent). Listed here are Annual and 5-yr rankings; see the online/paper issue for 10-yr and category-wise rankings.
    ANNUAL Ranking: #1-Putnam, #2-Fidelity, #3-PGIM, #4-Virtus, #5-Touchstone, #6-Nuveen/TIAA, #7-Rowe Price,…, #10-BlackRock,…, #12-Pimco, #13-State Street, #14-Vanguard,…,#17-DFA,…, #26-Morgan Stanley,…, #30-BNY Mellon,…, #32-Franklin Templeton,…, #34-Capital Group/AF,…, #38-Invesco,…, #45-J P Morgan.
    5-YEAR: #1-Putnam, #2-Fidelity, #3-Sit, #4-Amundi, #5-Virtus, #6-State Street, #7-DFA, #8-Nuveen/TIAA,…, #10-Pimco,…, #13-PGIM, #14-J P Morgan,…, #17-Vanguard,…, #25-Morgan Stanley, #26-BlackRock, #27-Rowe price,…, #29-BNY Mellon, #30-Capital Group/AF,…, #39-Invesco,…, #43-Franklin Templeton.
    LINK1 LINK2
  • Emerging Markets Anyone?
    Here is the data from MarketWatch which is more current than Fido. No changes to YTD data. And the data per MW ties to M* - both are as of 03/01/24.
    YTD_1_3_5_10
    FXAIX_7.97_32.11_11.32_14.78_12.77
    GSIHX_11.85_33.70_9.24_13.00_N/A
    NEAGX_15.64_43.34_12.25_24.13_14.37
    GQGPX_9.27_38.07_1.06_10.18_N/A
    So in effect, using more current MW and/or M* data, the relative performance of GQGPX is not any better!
    Bottom Line_1: 2023 and 2024 may very well be the go-go years for EMs, or at least for GQGPX!
    Bottom Line_2: Which of those funds would you have rather owned for those periods? Was venturing into a DEM worth your additional risk? Here's the biggie - Would you have stuck with GQGPX during its DOWN years?
    Bottom Line_3: Was diversifying to a top-performing FLG or SCG fund a better option than diversifying to a top-performing DEM?
    Bottom Line_4: It's SO HARD to consistently beat or at least track with the S&P but some funds do it. DEMs generally do not but GQGPX is worth a shot if so inclined to try.
  • Emerging Markets Anyone?
    @stillers ..."GQGPX is actually UP 9.36% over 5 years."
    According to M*, GQGPX has returned an annualized 10.18% over the last 5 years.
  • Emerging Markets Anyone?
    GQGPX is actually UP 9.36% over 5 years.
    EDIT_See corrected, more current data below thanks to @PRESSmUp. Thank you!
    It lags the S&P in all regularly shown interim periods and was very poor for the past 3 years.
    It is currently being fueled by its large stakes in India and Brazil, but also by its ~5% stake in (say what?) Domestic NVDA! Strip NVDA's parabolic TRs out of there and I trust you will have different TRs.
    YTD_1_3_5_10
    FXAIX_7.97_30.45_11.90_14.75_12.69
    GSIHX_11.85_20.58_7.82_11.95_N/A
    NEAGX_15.64_28.34_10.39_22.37_13.16
    GQGPX_9.27_26.41_0.31_9.36_N/A
    EDIT_See corrected, more current data below thanks to @PRESSmUp. Thank you!
    If it doesn't consistently beat or at least track with the S&P, and carries and ER of over 1% (1.2%), we are generally NOT interested. FLG GSIHX's ER at 1.14% and SCG NEAGX's at 1.85% are our two exceptions. But we believe their two HIGH ERs are reasonable given their results. (NEAGX is noted here as IMO SCs are a much more attractive play in 2024 than EMs and NEAGX's performance supports that notion.)
    Of course Domestic LC and even MC/SC can and do have indirect EM exposure. That's a given. But their respective performances are generally NOT driven by that exposure and are usually nominal to negligible. An investor really doesn't get much EM exposure unless they are holding DEM, Global and/or Foreign funds.
    And while many investors may not be aware of their EM exposure, having invested directly in EM stock and bond funds for a coupla years, we keenly are. (FNMIX was a favorite when John Carlson was the PM.) We have some direct EM exposure via GSIHX (mainly India and Brazil) but negligible, if any, in all other funds.
    Several years ago on the M* forum, stock and bond EMs were dissected ad nauseum. What I remember most about all that activity was a large group of retired investors, ourselves included, determined that there really is no need for direct EM stock or bond exposure in a retiree portfolio. The reasons: Why bother having to track and attempt to understand EM exposures? Why add that extra level of risk, when the TRs were not worthy of it?
    For adventurous and perhaps younger investors (and also for expert market timers-raise your hands), EMs can be a viable playground when the EM cycle is in the UP mode. But the risks are clearly elevated and the DROPS can and usually do shake out weak hands at just the wrong time. The Callan Table that I previously posted is a clear visual of the feast or famine inherent to this category.
    YMMV.
  • Emerging Markets Anyone?
    I own GQGPX and it's and don't mind it's 10+% Avg return over 5 yrs. Not bad when you consider both the Pandemic and the largest country allocation in EM index is struggling economically! Kept to a 2.5% allocation and part of my Int'l sleeve, it's a good option for those looking for a 'piece' of the action.
    FWIW - Int'l MF DODFX typically holds 15-20% in EM
    FWIW #2 - Most of the domestic giants in US make a lot of their $$$ from EM economies so you have exposure and may not realize it.
  • Question for Girouxheads out there
    @larryb - A little late to the party, but I use a combo of SCHD and TDVG, which is the ETF version of PRDGX referenced by Roy above. Large cap breakdown is 13/43/25, so it 's more blend than value. SCHD LC breakdown is 38/31/5. That's worked well for me, although yield for the TRP fund is only 1.19%.
  • frozen markets, range-bound
    6.4% YTD. Was 50% equity for most of January; currently about 70% equity. Trying to strike while the iron is hot. 76, retired, expenses covered, investing for heirs.
  • frozen markets, range-bound
    38% stocks, 50% bonds, 12% MM, YTD up 3.83%.
  • frozen markets, range-bound
    YTD. +7% 70% stocks, 20% bonds and 10% cash. I am 65 and retired.
  • Buy Sell Why: ad infinitum.
    @PRESSmUP, what is up 2.59 today? Your portfolio?
  • Buy Sell Why: ad infinitum.
    Well! You done GOOD! Just don't hold your breath, eh? MLP ET was my best performer. But it's just 5% of portfolio, by design. Don't wanna make too-big bets with single stocks. ET +2.32% just today, Friday.
  • frozen markets, range-bound
    BHB continues to hamper results, but I'd bet it's not their fault. Lots of knock-on effects from elsewhere, and the FED's recalcitrance to reduce interest rates. I see no indication that the bank has been imprudent or foolish or careless or has stopped making money. Low P/E. Nice dividend. Is this not a "widows and orphans" stock?
    I continue to CRAWL upward in tiny, labored baby-steps. Since Jan 1: +0.7%. Pathetic. 52 stocks 39 bonds 7 cash.
  • Buy Sell Why: ad infinitum.
    +2.59% today...what could possibly go wrong?